<p>siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

siRNA-based breast cancer therapy by suppressing 17β-hydroxysteroid dehydrogenase type 1 in an optimized xenograft cell and molecular biology model in vivo

Published:2019-02 Issue: Volume:Volume 13 Page:757-766
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Li Fang,Zhu ZhiHan^ORCID,Xue Man^ORCID,He WanHong,Zhang Ting,Feng LingLin,Lin ShengXiang

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sustained estradiol valerate delivery by microneedles: A new effective platform to construct estrogen-dependent tumor model;Journal of Drug Delivery Science and Technology;2024-10

2. Targeting the formation of estrogens for treatment of hormone dependent diseases–current status;Frontiers in Pharmacology;2023-04-28

3. RNA Interference in Experimental Animal Models: Its Application in Cancer Research and Therapy;Handbook of Animal Models and its Uses in Cancer Research;2023

4. siRNA and targeted delivery systems in breast cancer therapy;Clinical and Translational Oncology;2022-12-23

5. RNA Interference in Experimental Animal Models: Its Application in Cancer Research and Therapy;Handbook of Animal Models and its Uses in Cancer Research;2022-10-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP